Cargando…
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers
PURPOSE: Resistance to chemotherapy and radiotherapy is the primary cause of a poor prognosis in oncological patients. Researchers identified many possible mechanisms involved in gaining a therapy-resistant phenotype by cancer cells, including alterations in intracellular drug accumulation, detoxifi...
Autores principales: | Dorna, Dawid, Paluszczak, Jarosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587253/ https://www.ncbi.nlm.nih.gov/pubmed/37453969 http://dx.doi.org/10.1007/s00432-023-05136-9 |
Ejemplares similares
-
The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
por: Dorna, Dawid, et al.
Publicado: (2022) -
Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells
por: Kleszcz, Robert, et al.
Publicado: (2023) -
The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas
por: Paluszczak, Jarosław
Publicado: (2020) -
Head and neck cancer: metronomic chemotherapy
por: De Felice, Francesca, et al.
Publicado: (2015) -
Cancer stem cells in head and neck cancer
por: Allegra, Eugenia, et al.
Publicado: (2012)